Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Seqster Launches Developer Portal Delivering Longitudinal Health Data and Patient Engagement Directly Into Life Science Enterprise Workflows

Seqster PDM, Inc., the leading patient-centric healthcare technology company, announced at HIMSS 2022 it has launched its Seqster Developer Portal, allowing pharma sponsors, contract research organizations, and healthcare enterprises to integrate with its patient data retrieval and delivery system seamlessly.

Key Features of Seqster’s Partner API include:

  • Interactive API Reference section, allowing users to demo our API endpoints in real time with testable endpoints and one-click copyable code samples
  • Editable, interactive code samples available in 6 of the most popular programming languages, including HTTP (Curl), .NET (C#), Java, PHP, Python, Ruby, and TypeScript
  • Ability to export and download our Partner SDK in 15 formats, including Postman collections, OpenAPI (JSON, YAML), RAML, WADL, and WSDL

Download Our Top Whitepaper : Building Reliable and Secure Fintech Systems in 2022

“With the Seqster developer portal, pharma, life science, and healthcare enterprise clients can automate longitudinal health data collection for patients throughout their health journey- from pre-diagnosis, diagnosis and treatment, to study participation- as well as continuous long-term monitoring for outcomes research and longitudinal observation,” said Ardy Arianpour, Seqster CEO & Co-Founder. “The portal delivers health data in a readily-consumable format, allowing developers to rapidly integrate Seqster’s SDKs and APIs into their enterprise workflows.”

Clients can easily integrate the web portals used by their clinical research teams with a white-label branded instance of Seqster’s Research Portal through Single Sign-On (SSO) included in Seqster’s OAuth2-compliant Partner API.

Related Posts
1 of 33,444

Recommended AI News: The Shark Social Club NFT Is Geared up to Make a Huge Splash in the NFT Community

Enterprises that already offer mobile apps for patient engagement and clinical trials participation can add Seqster’s Mobile SDK as a plug-in library to their iPhone® and Android™ software development environments. The Mobile SDK documentation on the new Developer Portal includes:

  • Mobile SDK documentation using the latest documentation standards
  • Documentation and samples for both iOS and Android formats.
  • Well-formatted, readable code samples, copyable with one click
  • Detailed walkthroughs providing start to finish integration instructions

Seqster’s product suite has been integrated into decentralized trials, clinical studies, patient registries, and patient engagement platforms for Takeda Pharmaceuticals, United BioSource (UBC), National Pancreas Foundation (NPF). Seqster achieves a faster, more efficient and robust clinical trial for our clients, saving them both time and expense of retrieving traditional scanned medical records from individual providers. The patient experience includes a lifetime of health data, all in one place, retrieved as quickly and seamlessly as their mobile banking apps, which leads to higher compliance, lower attrition, longer streams of continuous data and repeat engagement for future trials.

Recommended AI News: Sparo Announces Partnership with ZamZam Token for Good to Explore Global Cryptocurrency for Charitable Giving

[To share your insights with us, please write to]

Comments are closed.